Study of blood counts in polycythemia and high platelets
Part of Blood & lymphatic clinical trials.
This study looks at people who have higher-than-normal hemoglobin and platelet counts. It aims to better understand the biology behind these blood changes and how they may be related to disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your hemoglobin is high (over 18 for men, over 16 for women)
- Your platelet count is high (over 450,000)
- You do not have a known acquired cause of both high hemoglobin and high platelets
- You do not have heart disease that affects blood flow
- You do not have severe lung (pulmonary) disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for adults with high hemoglobin levels (meaning their blood has too many red blood cells). It aims to learn more about this condition and help guide care.
This study tests whether lisinopril, a common blood pressure medication, can help lower red blood cell counts in people who have elevated hemoglobin levels. Researchers want to see if this drug could offer a simpler treatment option for this condition.
This trial studies proteins and red blood cell production in people with polycythemia (high red blood cell count) to understand its causes. It may help improve care for patients with this condition.
This study looks at how thick your blood is (blood viscosity) if you have polycythemia, a condition where your body makes too many red blood cells. It aims to understand the relationship between blood thickness and your red blood cell levels.
This study looks at how fats (lipids) in your blood affect blood cells called platelets, which help with clotting. It includes both healthy people and those with high cholesterol or other fat issues.
This is an observational study that follows people with certain blood disorders. It aims to learn more about how these conditions behave in real life, which can help improve future care.
Hear when a new Polycythemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.